256 related articles for article (PubMed ID: 9482355)
1. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.
Trojanowski JQ; Lee VM
Arch Neurol; 1998 Feb; 55(2):151-2. PubMed ID: 9482355
[No Abstract] [Full Text] [Related]
2. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
3. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
[TBL] [Abstract][Full Text] [Related]
4. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
5. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies.
Sharma N; McLean PJ; Kawamata H; Irizarry MC; Hyman BT
Acta Neuropathol; 2001 Oct; 102(4):329-34. PubMed ID: 11603807
[TBL] [Abstract][Full Text] [Related]
7. Proteomic approach to studying Parkinson's disease.
Zhang J; Goodlett DR
Mol Neurobiol; 2004 Jun; 29(3):271-88. PubMed ID: 15181239
[TBL] [Abstract][Full Text] [Related]
8. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Conway KA; Harper JD; Lansbury PT
Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
[TBL] [Abstract][Full Text] [Related]
10. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
11. Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains.
van Horssen J; de Vos RA; Steur EN; David G; Wesseling P; de Waal RM; Verbeek MM
J Alzheimers Dis; 2004 Oct; 6(5):469-74. PubMed ID: 15505367
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.
El-Agnaf OM; Curran MD; Wallace A; Middleton D; Murgatroyd C; Curtis A; Perry R; Jaros E
Neuroreport; 1998 Dec; 9(17):3925-7. PubMed ID: 9875730
[TBL] [Abstract][Full Text] [Related]
13. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease.
Giasson BI; Jakes R; Goedert M; Duda JE; Leight S; Trojanowski JQ; Lee VM
J Neurosci Res; 2000 Feb; 59(4):528-33. PubMed ID: 10679792
[TBL] [Abstract][Full Text] [Related]
14. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
Voronkov DN; Salkov VN; Anufriev PL; Khudoerkov RM
Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
[TBL] [Abstract][Full Text] [Related]
15. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.
Kowall NW; Hantraye P; Brouillet E; Beal MF; McKee AC; Ferrante RJ
Neuroreport; 2000 Jan; 11(1):211-3. PubMed ID: 10683860
[TBL] [Abstract][Full Text] [Related]
16. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
[TBL] [Abstract][Full Text] [Related]
17. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.
Crowther RA; Daniel SE; Goedert M
Neurosci Lett; 2000 Oct; 292(2):128-30. PubMed ID: 10998565
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice.
Barbieri S; Hofele K; Wiederhold KH; Probst A; Mistl C; Danner S; Kauffmann S; Sommer B; Spooren W; Tolnay M; Bilbe G; van der Putten H
Adv Exp Med Biol; 2001; 487():147-67. PubMed ID: 11403156
[No Abstract] [Full Text] [Related]
20. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]